TAF4
protein-codingTATA-box binding protein associated factor 4, the group of General transcription factor IID complex subunits
Gene summary
Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the larger subunits of TFIID that has been shown to potentiate transcriptional activation by retinoic acid, thyroid hormone and vitamin D3 receptors. In addition, this subunit interacts with the transcription factor CREB, which has a glutamine-rich activation domain, and binds to other proteins containing glutamine-rich regions. Aberrant binding to this subunit by proteins with expanded polyglutamine regions has been suggested as one of the pathogenetic mechanisms underlying a group of neurodegenerative disorders referred to as polyglutamine diseases. [provided by RefSeq, Jul 2008]
- TAF4A
- TAF2C1
- TAF2C
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~112.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0957536
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0957536
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TAF4 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003185.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 27 | 1 | 31 | ||
| missense | 1 | 236 | 18 | 1 | 256 | |
| nonsense | 5 | 3 | 2 | 10 | ||
| start loss | 0 | |||||
| frameshift | 7 | 15 | 7 | 29 | ||
| splice donor/acceptor (+/-2bp) | 5 | 5 | ||||
| Total | 12 | 19 | 253 | 45 | 2 | 331 |
Highest pathogenic variant AF is 0.000007360771
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003176.2 | 15 | MANE Select | |
| Ensembl | ENSP00000252996.3 | 15 | MANE Select | |
| Ensembl | ENSP00000476270.1 | 3 | Standard | |
| Ensembl | ENSP00000476294.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Huntington,s disease - Homo sapiens (human)
- Basal transcription factors - Homo sapiens (human)
- Herpes simplex infection - Homo sapiens (human)
- Disease
- Gene expression (Transcription)
Biological Process
- ovarian follicle development
- DNA-templated transcription, initiation
- transcription by RNA polymerase II
- transcription initiation from RNA polymerase II promoter
- viral process
Molecular Function
- DNA binding
- DNA-binding transcription factor activity
- transcription coactivator activity
- protein binding
- transcription factor binding
Cellular Component
- nuclear chromatin
- nucleoplasm
- transcription factor TFIID complex
- cytosol
- protein-containing complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000252996
- Coding exons
- 15
- Length
- 112342
- Individuals with no LoFs
- 108127
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 1
- Defined
- 108128
- p
- 0.00000462
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.68 | 287 | 447 | 0.643 | 0.0000281 | 6715 |
| Missense (PolyPhen) | 95 | 214.62 | 0.44263 | 2374 | ||
| Synonymous | -1.82 | 236 | 203 | 1.16 | 0.0000147 | 2473 |
| Loss of Function | 5.61 | 0 | 36.7 | 0.00 | 0.00000182 | 436 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000010 | 0.000010 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Part of the TFIID complex, a multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors. Potentiates transcriptional activation by the AF-2S of the retinoic acid, vitamin D3 and thyroid hormone.;
Recessive Scores
- pRec
- 0.185
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- E
- Essential (gene trap)
- K
- Indispensability pred.
- N
- Indispensability score
- 0.309
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |